Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-901-0 | CAS number: 5538-94-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 May 1988 - 15 August 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
- Deviations:
- not specified
- GLP compliance:
- yes
Test material
- Reference substance name:
- Reference substance 001
- Cas Number:
- 7173-51-5
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Batch No.of test material: B-1889
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Twenty eight male and 28 female weanling rats (F0 generation) were exposed to the substance by dietary inclusion for a total of 10-week pre-breed exposure period. Exposures continued through mating, gestation, parturition and lactation. Exposures continued through mating, gestation, parturition and lactation of the second litters.
- Details on mating procedure:
- Following a 10-week pre-breed exposure period the F0 rats were randomly paired within dose groups for a three week mating period to produce the F1A generation. At least 10 days after the weaning of the F1A litters, the Fo parents were paired again (with different male-female pairing within the dose groups than employed for the F1A breed) for 3 weeks to produce the F1B generation.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The concentration of the substance in the test diets was determined using gas chromatography. For the first 4 weeks of teh study, test diets from all diets were analysed for concentrations of the substance prior to administration of the diets to the animals. For the remaining 60 weeks of teh study, all test diets from every fourth preparation were analysed after administration of the diets to the study animals. Homogeneity and stability analyses of the substance in the diets were performed prior to the start of the test diet administration.
- Details on study schedule:
- Following a 10-week pre-breed exposure period the F0 rats were randomly paired within dose groups for a three week mating period to produce the F1A generation. At least 10 days after the weaning of the F1A litters, the F0 parents were paired again (with different male-female pairing within the dose groups than employed for the F1A breed) for 3 weeks to produce the F1B generation. After the F1B pups were weaned, the F0 animals were necropsied and high dose and control animals were examined for histopathologic lesions. At weaning, 28 F1B weanlings/sex/group were randomly selected as parents of the subsequent generation. Selected F1 parents were exposed to the same dietary concentrations of the substance as their parents for at least 10 weeks. After their pre-breed exposure the F1 animals were paired to produce F2A and F2B offspring.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 ppm
- Dose / conc.:
- 300 ppm
- Dose / conc.:
- 750 ppm
- Dose / conc.:
- 1 500 ppm
- No. of animals per sex per dose:
- 28/sex/dose
- Control animals:
- yes, plain diet
- Details on study design:
- Twenty eight F0 rats/sex/dose were bred twice to produce F1A and F1B litters. Selected males and females from F1B litters were used as parents of the F2 generation. Twenty eight F1 pups/sex/dose, exposed to the same dietary concentration of the substance as their parents, were subsequently bred twice to produce F2A and F2B litters.
Examinations
- Parental animals: Observations and examinations:
- PARAMETERS EXAMINED
The following parameters were examined in F0 to produce F1A/F1B litters and F1 to produce F2A/F2B litters: Mating index (males), mating index (males), fertility index (females) and fertility index (males). - Litter observations:
- PARAMETERS EXAMINED
The following parameters were examined in F1A/F1B / F2A/F2B offspring: gestational index, live birth index, 4-day survival index (precull and postcull), 14-day survival index, 21-day survival index, lactation index, 28-day survival index.
[number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities, anogenital distance (AGD), presence of nipples/areolae in male pups, other:]
GROSS EXAMINATION OF DEAD PUPS:
[no / yes, for external and internal abnormalities; possible cause of death was/was not determined for pups born or found dead.] - Statistics:
- The unit of comparison was the male, pregnant female or the litter. Results of the qunatitative continuous variables (e.g. body weights, food consumption, organ weights, etc) were intercompared for the three treatment groups and one control group by use of Levene's test for equal variances; analysis of variance (ANOVA) and t-tests. When Levene's test indicated homogeneous variances and the ANOVA was significant, the pooled t-test was used for pair-wise comparisons. When Levene's test indicated heterogeneous variances, all groups were compared by an ANOVA for unequal variances followed, when necessary, by the separate variance t-test for pairwise comparisons. The significance levels for the t-tests comparisons were corrected by the Bonferroni method. Nonparametric data were statistically evaluated using the Kruskal-Wallis test followed by the Mann-Whitney U test for pairwise comparisons when appropriate. Frequency data were compared using the Fisher's exact test. For all statistical tests, the fidcial limit of 0.5 (two-tailed) was used as the criterion for statistical significance.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Reduced body weight and body weight gain at the top concentration begining one week after treatment.
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- Substantial reductions in food consumption were observed throughout the pre-breed period in F0 animals at the top concentration.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
Reproductive function / performance (P0)
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- Gestational length as well as mating, fertility and gestational indices were unaffected by treatment. Body weights and bodyu weight gains at 300 and 750 ppm were essentially equivalent to control values throughout gestation. Gestational food consumption was unaffected by treatment. There were no differences across the groups for reproductive parameters for F0 parents for the F1A and F1B breeds.
Results: P1 (second parental generation)
General toxicity (P1)
- Clinical signs:
- effects observed, non-treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Males and females at 1500 ppm exhibited consistently reduced body weights throughout the entire treatment period. Significant weight gain depression was noted at 1500 ppm.
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- Food consumption for the F1 males and females was reduced at 1500 ppm throughout the treatment period. No effects on food consumption were noted in F1 males and females at 300 and 750 ppm.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
Reproductive function / performance (P1)
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- Maternal gestational body weights, but not weight gains, were reduced at 1500 ppm.
Effect levels (P1)
open allclose all
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- 750 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 500 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- reproductive performance
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- effects observed, non-treatment-related
- Mortality / viability:
- mortality observed, non-treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Pup body weights and body weight gains were unaffected by treatment though lactational day 7. From day 14 through weaning on lactational day 21, and postweaning, on day 28, body weights of male and female pups at 1500 ppm were reduced. Corresponding body weight gains for lactational days 7-21 and 21-28 (postweaning) were reduced at 1500 ppm. Body weights and weight gains of pups at 750 and 300 ppm were unaffected by treatment.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not examined
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not examined
Effect levels (F1)
open allclose all
- Key result
- Dose descriptor:
- NOEL
- Generation:
- F1
- Effect level:
- 750 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 500 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Reproductive performance
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Results: F2 generation
General toxicity (F2)
- Clinical signs:
- effects observed, non-treatment-related
- Mortality / viability:
- mortality observed, non-treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- F2B pup body weights per litter were equivalent through lactational day 4. From lactational day 7 through weaning on day 21, and postweaning, on day 28, body weights of F2B pups at 1500 ppm were reduced. Concurrent F2B pup weight gain reductions were observed at 1500 ppm from day 4-28. There were no observable effects of treatment on body weight at 750 and 300 ppm.
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- not examined
- Histopathological findings:
- not examined
Developmental neurotoxicity (F2)
- Behaviour (functional findings):
- not examined
Developmental immunotoxicity (F2)
- Developmental immunotoxicity:
- not examined
Effect levels (F2)
open allclose all
- Key result
- Dose descriptor:
- NOEL
- Generation:
- F2
- Effect level:
- 750 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F2
- Effect level:
- 1 500 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Overall reproductive toxicity
- Key result
- Reproductive effects observed:
- no
- Lowest effective dose / conc.:
- 1 500 ppm
- Treatment related:
- no
Applicant's summary and conclusion
- Conclusions:
- Exposure of rats to the substance at concentrations of 300, 750 aand 1500 ppm in the diet for two generations resulted in well-defined parental and postnatal toxicity at 1500 ppm without any adverse effects on reproductive performance. The NOEL was 750 ppm for both parents and offspring, indicating that there was no increased risk to the offspring in the absence of indications of adult toxicity.
- Executive summary:
The potential of the substance to produce alterations in parental fertility, maternal pregnancy and lactation, and growth and development of the offspring for two generations and two litters per generation was evaluated in Sprague Dawley rats. The substance was administered via the diet at concentrations of 300, 750 aand 1500 ppm. A well-defined parental and postnatal toxicity as evidenced by body weight reductions occurred at 1500 ppm without any adverse effects on reproductive performance. The NOEL was 750 ppm for both parents and offspring, indicating that there was no increased risk to the offspring in the absence of indications of adult toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.